vs
Acadia Healthcare Company, Inc.（ACHC）与AMERICAN AXLE & MANUFACTURING HOLDINGS INC（AXL）财务数据对比。点击上方公司名可切换其他公司
AMERICAN AXLE & MANUFACTURING HOLDINGS INC的季度营收约是Acadia Healthcare Company, Inc.的1.7倍（$1.4B vs $829.0M），Acadia Healthcare Company, Inc.净利率更高（0.5% vs -5.4%，领先6.0%），Acadia Healthcare Company, Inc.同比增速更快（7.5% vs 0.2%），过去两年Acadia Healthcare Company, Inc.的营收复合增速更高（2.0% vs -7.2%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
美国车桥制造控股有限公司总部位于密歇根州底特律，是一家美国汽车传动轴与动力传动系统零部件及系统制造商，在汽车传动领域拥有成熟的技术与产能，为全球多家车企供应相关核心配件。
ACHC vs AXL — 直观对比
营收规模更大
AXL
是对方的1.7倍
$829.0M
营收增速更快
ACHC
高出7.3%
0.2%
净利率更高
ACHC
高出6.0%
-5.4%
两年增速更快
ACHC
近两年复合增速
-7.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $1.4B |
| 净利润 | $4.5M | $-75.3M |
| 毛利率 | — | 10.2% |
| 营业利润率 | — | -2.4% |
| 净利率 | 0.5% | -5.4% |
| 营收同比 | 7.5% | 0.2% |
| 净利润同比 | -50.8% | -449.6% |
| 每股收益（稀释后） | $0.05 | $-0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCAXL
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $1.4B | ||
| Q3 25 | $851.6M | $1.5B | ||
| Q2 25 | $869.2M | $1.5B | ||
| Q1 25 | $770.5M | $1.4B | ||
| Q4 24 | $774.2M | $1.4B | ||
| Q3 24 | $815.6M | $1.5B | ||
| Q2 24 | $796.0M | $1.6B |
净利润ACHCAXL
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $-75.3M | ||
| Q3 25 | $36.2M | $9.2M | ||
| Q2 25 | $30.1M | $39.3M | ||
| Q1 25 | $8.4M | $7.1M | ||
| Q4 24 | $32.6M | $-13.7M | ||
| Q3 24 | $68.1M | $10.0M | ||
| Q2 24 | $78.5M | $18.2M |
毛利率ACHCAXL
| Q1 26 | — | — | ||
| Q4 25 | — | 10.2% | ||
| Q3 25 | — | 12.6% | ||
| Q2 25 | — | 13.1% | ||
| Q1 25 | — | 12.3% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | — | 11.4% | ||
| Q2 24 | — | 13.3% |
营业利润率ACHCAXL
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | -2.4% | ||
| Q3 25 | 4.7% | 3.2% | ||
| Q2 25 | 5.8% | 3.6% | ||
| Q1 25 | 1.7% | 3.0% | ||
| Q4 24 | 4.9% | 2.6% | ||
| Q3 24 | 12.1% | 2.8% | ||
| Q2 24 | 13.4% | 5.3% |
净利率ACHCAXL
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | -5.4% | ||
| Q3 25 | 4.3% | 0.6% | ||
| Q2 25 | 3.5% | 2.6% | ||
| Q1 25 | 1.1% | 0.5% | ||
| Q4 24 | 4.2% | -1.0% | ||
| Q3 24 | 8.4% | 0.7% | ||
| Q2 24 | 9.9% | 1.1% |
每股收益（稀释后）ACHCAXL
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $-0.62 | ||
| Q3 25 | $0.40 | $0.07 | ||
| Q2 25 | $0.33 | $0.32 | ||
| Q1 25 | $0.09 | $0.06 | ||
| Q4 24 | $0.36 | $-0.11 | ||
| Q3 24 | $0.74 | $0.08 | ||
| Q2 24 | $0.85 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $708.9M |
| 总债务越低越好 | $2.5B | $4.0B |
| 股东权益账面价值 | $2.0B | $640.0M |
| 总资产 | $5.5B | $6.7B |
| 负债/权益比越低杠杆越低 | 1.29× | 6.31× |
8季度趋势，按日历期对齐
现金及短期投资ACHCAXL
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $708.9M | ||
| Q3 25 | $118.7M | $714.1M | ||
| Q2 25 | $131.4M | $586.5M | ||
| Q1 25 | $91.2M | $549.2M | ||
| Q4 24 | $76.3M | $552.9M | ||
| Q3 24 | $82.1M | $542.5M | ||
| Q2 24 | $77.2M | $519.9M |
总债务ACHCAXL
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $4.0B | ||
| Q3 25 | $2.3B | $2.6B | ||
| Q2 25 | $2.3B | $2.6B | ||
| Q1 25 | $2.2B | $2.6B | ||
| Q4 24 | $2.0B | $2.6B | ||
| Q3 24 | $1.9B | $2.6B | ||
| Q2 24 | $1.8B | $2.7B |
股东权益ACHCAXL
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $640.0M | ||
| Q3 25 | $3.1B | $718.4M | ||
| Q2 25 | $3.1B | $673.0M | ||
| Q1 25 | $3.0B | $596.3M | ||
| Q4 24 | $3.1B | $562.8M | ||
| Q3 24 | $3.0B | $616.3M | ||
| Q2 24 | $3.0B | $609.6M |
总资产ACHCAXL
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $6.7B | ||
| Q3 25 | $6.4B | $5.3B | ||
| Q2 25 | $6.3B | $5.3B | ||
| Q1 25 | $6.1B | $5.1B | ||
| Q4 24 | $6.0B | $5.1B | ||
| Q3 24 | $5.9B | $5.3B | ||
| Q2 24 | $5.7B | $5.3B |
负债/权益比ACHCAXL
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 6.31× | ||
| Q3 25 | 0.74× | 3.61× | ||
| Q2 25 | 0.74× | 3.86× | ||
| Q1 25 | 0.72× | 4.38× | ||
| Q4 24 | 0.64× | 4.58× | ||
| Q3 24 | 0.62× | 4.28× | ||
| Q2 24 | 0.62× | 4.42× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | $120.5M |
| 自由现金流经营现金流 - 资本支出 | — | $54.7M |
| 自由现金流率自由现金流/营收 | — | 4.0% |
| 资本支出强度资本支出/营收 | — | 4.8% |
| 现金转化率经营现金流/净利润 | 13.78× | — |
| 过去12个月自由现金流最近4个季度 | — | $155.1M |
8季度趋势，按日历期对齐
经营现金流ACHCAXL
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $120.5M | ||
| Q3 25 | $73.2M | $143.3M | ||
| Q2 25 | $133.5M | $91.9M | ||
| Q1 25 | $11.5M | $55.9M | ||
| Q4 24 | $116.7M | $151.2M | ||
| Q3 24 | $163.1M | $143.6M | ||
| Q2 24 | $171.1M | $142.8M |
自由现金流ACHCAXL
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $54.7M | ||
| Q3 25 | $-63.0M | $79.2M | ||
| Q2 25 | $-34.2M | $34.6M | ||
| Q1 25 | $-163.2M | $-13.4M | ||
| Q4 24 | $-86.8M | $73.2M | ||
| Q3 24 | $-27.1M | $70.4M | ||
| Q2 24 | $16.9M | $94.0M |
自由现金流率ACHCAXL
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 4.0% | ||
| Q3 25 | -7.4% | 5.3% | ||
| Q2 25 | -3.9% | 2.3% | ||
| Q1 25 | -21.2% | -0.9% | ||
| Q4 24 | -11.2% | 5.3% | ||
| Q3 24 | -3.3% | 4.7% | ||
| Q2 24 | 2.1% | 5.8% |
资本支出强度ACHCAXL
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 4.8% | ||
| Q3 25 | 16.0% | 4.3% | ||
| Q2 25 | 19.3% | 3.7% | ||
| Q1 25 | 22.7% | 4.9% | ||
| Q4 24 | 26.3% | 5.6% | ||
| Q3 24 | 23.3% | 4.9% | ||
| Q2 24 | 19.4% | 3.0% |
现金转化率ACHCAXL
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | 15.58× | ||
| Q2 25 | 4.43× | 2.34× | ||
| Q1 25 | 1.37× | 7.87× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | 14.36× | ||
| Q2 24 | 2.18× | 7.85× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
AXL
| Driveline | $748.4M | 54% |
| Other | $345.7M | 25% |
| Metal Forming | $289.8M | 21% |
